<SEC-DOCUMENT>0001209191-20-025020-index.html : 20200417
<SEC-HEADER>0001209191-20-025020.hdr.sgml : 20200417
<ACCEPTANCE-DATETIME>20200417210744
ACCESSION NUMBER:		0001209191-20-025020
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200415
FILED AS OF DATE:		20200417
DATE AS OF CHANGE:		20200417

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Torti Frank
		CENTRAL INDEX KEY:			0001647805

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37418
		FILM NUMBER:		20801099

	MAIL ADDRESS:	
		STREET 1:		2855 SAND HILL ROAD
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Axovant Gene Therapies Ltd.
		CENTRAL INDEX KEY:			0001636050
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981333697
		FISCAL YEAR END:			0331

	BUSINESS ADDRESS:	
		STREET 1:		11-12 ST. JAMES'S SQUARE
		STREET 2:		SUITE 1, 3RD FLOOR
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1Y 4LB
		BUSINESS PHONE:		44 203 318 9708

	MAIL ADDRESS:	
		STREET 1:		11 TIMES SQUARE
		STREET 2:		33RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Axovant Sciences Ltd.
		DATE OF NAME CHANGE:	20150324

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Axovant Sciences, Inc.
		DATE OF NAME CHANGE:	20150324

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Roivant Neurosciences Ltd.
		DATE OF NAME CHANGE:	20150309
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>